Rxi Pharmaceuticals Corp (NASDAQ:RXII)

0.50
Delayed Data
As of May 22
 +0.0049 / +0.99%
Today’s Change
0.48
Today|||52-Week Range
3.98
-68.75%
Year-to-Date

Today’s Trading

Previous close0.50
Today’s open0.50
Day’s range0.48 - 0.50
Volume469,918
Average volume (3 months)994,942
Market cap$18.1M
Dividend yield--
Data as of 4:00pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)+72.57%
Earnings growth (this year)+56.33%
Earnings growth (next 5 years)--
Revenue growth (last year)-82.21%
P/E ratioNM
Price/Sales368.74
Price/Book9.42

Competitors

 Today’s
change
Today’s
% change
CBMXCombiMatrix Corp-0.09-5.20%
NSPHNanosphere Inc-0.09-2.36%
WGBSWaferGen Bio-systems...-0.01-0.25%
ICCCImmuCell Corp+0.10+1.38%
Data as of 4:00pm ET, 05/22/2015

Financials

Last reporting dateMay 13, 2015
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$71.0K
Annual profit (last year)-$8.8M
Net profit margin-12,394.37%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Geert Cauwenbergh
Vice President-
Research
Karen Bulock
Corporate headquarters
Westborough, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers